跳至主要内容
临床试验/NCT07622680
NCT07622680已完成不适用

Comparative Effects of Mediterranean and DASH Diet on Hepatic Function in Patients Suffering From NAFLD

University of Lahore1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2025年11月12日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75
试验地点
1

研究概览

简要总结

Participants were assigned into three groups Control group recieving general dietary guidelines, Mediterranean diet intervention group DASH dietary intervention group

详细描述

Written permission was taken from the ethical board for data collection. After taking informed consent from patients in written form, the researcher used self-administered questionnaire or Performa to gather data. NAFLD patients (both genders) of age 25 to 70 years were included.

  1. Screening:

The participants eligible under inclusion criteria will be enrolled. The baseline data (weight, height, BMI, waist circumference, LFT's, Lipid profile, blood pressure). The target population between 25-70 years were selected. 2. Allocation:

The participants were assigned into three groups; control group was given dietary guidelines followed by medication; one group was given Mediterranean diet (T1) and other group was given DASH diet (T2) along with conventional therapy 3. Follow up:

The follow up of patient were conducted monthly, all laboratory test (LFT's, Lipid profile, blood pressure) were conducted on 1st and after 8th week. The baseline and post-test study were compared to test hypothesis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (25-70 years) of both genders with BMI (above 25 kg/m2).
  • Fatty liver patients with mild to moderate values of Alanine Transaminase (ALT) level range from mild to moderate (30-100U/L)
  • Fatty liver patients having Aspartate Aminotransferase (AST) level range from mild to moderate (200-600 IU/L).
  • Fatty liver patients having Gamma-Glutamyl Transferase (GGT level range from mild to moderate(120-300 U/L) were included.

排除标准

  • Lactating and pregnant women were not included.
  • Patients who are using any kind of medicine.
  • Adults suffering from critical health conditions, including cancer.

研究者

发起方
University of Lahore
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Aslam

Clinical Head University Institute of Diet and Nutritional Sciences

University of Lahore

研究点 (1)

Loading locations...

相似试验